We are live on ! Find out more
2Xideas

2Xideas Portfolio holdings

AUM $187M Turnover 22.92%
1-Year Est. Return 16.78%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+16.78%
3 Year Est. Return
+68.27%
5 Year Est. Return
+58.1%
10 Year Est. Return
–
AUM
$474M
AUM Growth
-$107M
Cap. Flow
-$96.3M
Cap. Flow %
-20.34%
Top 10 Hldgs %
52.08%
Holding
62
New
5
Increased
6
Reduced
45
Closed
6
Avg Time Held
2.6 years
Top 10 Avg Time Held
1.8 years
Top 20 Avg Time Held
1.9 years

Top Buys

Rank Stock Value
1
BRO icon
Brown & Brown
BRO
+$6.89M
2
MANH icon
Manhattan Associates
MANH
+$3.95M
3
SNPS icon
Synopsys
SNPS
+$2.78M
4
RMD icon
ResMed
RMD
+$2.29M
5
VERX icon
Vertex
VERX
+$1.83M

Top Sells

Rank Stock Value
1
PTC icon
PTC
PTC
+$11.3M
2
FERG icon
Ferguson
FERG
+$9.43M
3
ANSS icon
Ansys
ANSS
+$6.98M
4
WSO icon
Watsco
WSO
+$6.62M
5
BLD icon
TopBuild
BLD
+$5.48M

Sector Composition

Rank Sector Weight
1 Technology 32.05%
2 Healthcare 26.3%
3 Financials 22.22%
4 Industrials 8.26%
5 Consumer Discretionary 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ICE icon
1
Intercontinental Exchange
ICE
$96.8B
$44.5M 9.4%
264,349
-17,838
-6% -$3.19M
2020 Q4
19 quarters
PTC icon
2
PTC
PTC
$21.3B
$42.6M 8.99%
209,680
-55,271
-21% -$11.3M
2022 Q3
12 quarters
FTNT icon
3
Fortinet
FTNT
$94.3B
$42.4M 8.96%
504,805
+19,592
+4% +$1.75M
2020 Q4
19 quarters
EW icon
4
Edwards Lifesciences
EW
$59.4B
$37.8M 7.99%
486,257
-34,454
-7% -$2.69M
2020 Q4
19 quarters
RMD icon
5
ResMed
RMD
$33.6B
$22.9M 4.83%
83,611
+8,397
+11% +$2.29M
2020 Q4
19 quarters
ADSK icon
6
Autodesk
ADSK
$51.9B
$13.9M 2.92%
43,605
-11,074
-20% -$3.37M
2024 Q2
5 quarters
HALO icon
7
Halozyme
HALO
$10.6B
$11.6M 2.46%
158,824
-25,722
-14% -$1.71M
2022 Q2
13 quarters
CSGP icon
8
CoStar Group
CSGP
$12B
$10.5M 2.21%
124,002
-36,165
-23% -$3.2M
2020 Q4
19 quarters
BAM icon
9
Brookfield Asset Management
BAM
$79.9B
$10.4M 2.2%
183,479
+14,221
+8% +$846K
2023 Q4
7 quarters
PLNT icon
10
Planet Fitness
PLNT
$4.48B
$10M 2.11%
96,256
-16,638
-15% -$1.77M
2024 Q4
3 quarters
RYAN icon
11
Ryan Specialty Holdings
RYAN
$5.75B
$9.7M 2.05%
172,653
-29,166
-14% -$1.73M
2024 Q1
6 quarters
IQV icon
12
IQVIA
IQV
$41B
$9.6M 2.02%
50,475
-12,419
-20% -$2.26M
2020 Q4
19 quarters
KNSL icon
13
Kinsale Capital Group
KNSL
$9.01B
$9.6M 2.02%
22,523
-4,142
-16% -$1.88M
2021 Q3
16 quarters
DXCM icon
14
DexCom
DXCM
$29.9B
$9.1M 1.92%
135,199
-8,900
-6% -$704K
2025 Q1
2 quarters
FERG icon
15
Ferguson
FERG
$47.4B
$8.84M 1.87%
39,377
-41,628
-51% -$9.43M
2024 Q3
4 quarters
KLAC icon
16
KLA
KLAC
$171B
$8.5M 1.8%
78,820
-29,280
-27% -$2.73M
2023 Q2
9 quarters
CCC icon
17
CCC Intelligent Solutions
CCC
$4.54B
$7.86M 1.66%
862,315
-23,407
-3% -$226K
2024 Q4
3 quarters
NBIX icon
18
Neurocrine Biosciences
NBIX
$15.6B
$7.13M 1.51%
50,797
-17,016
-25% -$2.31M
2024 Q4
3 quarters
NYT icon
19
New York Times
NYT
$11.2B
$6.76M 1.43%
117,819
-31,895
-21% -$1.82M
2021 Q2
17 quarters
BRO icon
20
Brown & Brown
BRO
$24.8B
$6.63M 1.4%
+70,685
New +$6.89M
2025 Q3
0 quarters
MSCI icon
21
MSCI
MSCI
$45.1B
$6.48M 1.37%
11,428
-2,467
-18% -$1.39M
2020 Q4
19 quarters
LPLA icon
22
LPL Financial
LPLA
$21.2B
$6.34M 1.34%
19,071
-368
-2% -$133K
2024 Q2
5 quarters
EXLS icon
23
EXL Service
EXLS
$6.39B
$6.23M 1.32%
141,444
-29,719
-17% -$1.29M
2024 Q4
3 quarters
KEYS icon
24
Keysight
KEYS
$46.5B
$6.04M 1.28%
34,535
-7,138
-17% -$1.19M
2025 Q1
2 quarters
LH icon
25
Labcorp
LH
$29.8B
$5.99M 1.27%
20,870
-7,051
-25% -$1.89M
2022 Q4
11 quarters

Similar funds

2Xideas's Q3 2025 Portfolio in Review

As of Q3 2025, 2Xideas held 62 positions worth $474M, down 18% from $581M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

2Xideas withdrew a net $96.3M in Q3 2025, closing 6 positions and reducing 45 holdings. Its most notable exit was Ansys, an estimated $6.98M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

Against the trend, 2Xideas opened a new position in Brown & Brown worth $6.63M.

  • 2Xideas's largest Q3 2025 buy was Brown & Brown: 70,685 shares worth $6.63M.
  • 2Xideas added most to ResMed in Q3 2025, an estimated $2.29M increase.
  • 2Xideas's biggest Q3 2025 reduction was PTC, cutting an estimated $11.3M.
  • 2Xideas fully exited Ansys in Q3 2025, selling an estimated $6.98M.
  • 2Xideas's ten largest holdings make up 52% of its $474M portfolio in Q3 2025.
  • 2Xideas opened 5 new positions and closed 6 in Q3 2025.
  • 2Xideas's portfolio value fell 18% quarter-over-quarter to $474M.

Based on 2Xideas's 13F filing for Q3 2025, filed 14 Nov 2025.